ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO)

Q: What does CUSIP 00166B105 represent in this 13F holders report?

CUSIP 00166B105 is the security identifier for ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share in Q1 2025?

83 institutional investors reported ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share for Q1 2025. Use the holders table for investor-level position and value details.

CUSIP: 00166B105

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 132,570,600
Total 13F shares: 34,764,459
Share change: -6,261,514
Total reported value: $21,657,278
Put/Call ratio: 109%
Price per share: $0.62
Number of holders: 83
Value change: -$4,297,920
Number of buys: 33
Number of sells: 38

Quarterly Holders Quick Answers

What is CUSIP 00166B105?
CUSIP 00166B105 identifies ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2025
Previous quarter: Q4 2024

Recent filing periods for CUSIP 00166B105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
LSV Associates, LLC	3/4/5	10%+ Owner	— class O/S missing	4,526,963	$61,575,751	—	13 Dec 2021	3/4/5
venBio Partners LLC	13F	Company	7.3%	9,699,925	$16,198,875	—	31 Dec 2024	13F
Redmile Group, LLC	13F	Company	2.8%	3,689,611	$6,161,650	—	31 Dec 2024	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	2.5%	3,296,883	$5,505,795	—	31 Dec 2024	13F
MORGAN STANLEY	13F	Company	1.9%	2,499,102	$4,173,500	—	31 Dec 2024	13F
BlackRock, Inc.	13F	Company	1.8%	2,384,247	$3,981,691	—	31 Dec 2024	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.6%	2,129,110	$3,555,614	—	31 Dec 2024	13F
VANGUARD GROUP INC	13F	Company	1.4%	1,887,002	$3,151,294	—	31 Dec 2024	13F
FMR LLC	13F 13D/G	Company	3.4% from 13D/G	1,851,556	$3,092,098	—	31 Dec 2024	13F 13D/G
MPM BioImpact LLC	13F	Company	1%	1,391,434	$2,323,695	—	31 Dec 2024	13F
HBM Healthcare Investments (Cayman) Ltd.	13D/G	—	8.4%	4,500,000	$2,295,000	+$547,266	31 Mar 2025	13D/G
Almitas Capital LLC	13F	Company	0.92%	1,222,945	$2,042,318	—	31 Dec 2024	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.84%	1,109,448	$1,851,000	—	31 Dec 2024	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.78%	1,035,326	$1,728,994	—	31 Dec 2024	13F
TANG CAPITAL PARTNERS LP	13D/G	TANG CAPITAL MANAGEMENT, LLC	6.3%	3,296,883	$1,681,410	$0	31 Dec 2024	13D/G
BANK OF MONTREAL /CAN/	13F	Company	0.62%	826,582	$1,380,392	—	31 Dec 2024	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.62%	823,900	$1,375,913	—	31 Dec 2024	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.56%	740,106	$1,236,239	—	31 Dec 2024	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.53%	704,131	$1,175,899	—	31 Dec 2024	13F
STATE STREET CORP	13F	Company	0.52%	684,123	$1,142,485	—	31 Dec 2024	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.43%	569,009	$950,245	—	31 Dec 2024	13F
Privium Fund Management B.V.	13F	Company	0.38%	509,059	$850,129	—	31 Dec 2024	13F
Sophia Randolph	3/4/5	CHIEF MEDICAL OFFICER	— mixed-class rows	420,711 mixed-class rows	$840,334	—	14 Aug 2024	3/4/5
UBS Group AG	13F	Company	0.31%	408,056	$681,454	—	31 Dec 2024	13F
Jaume Pons	3/4/5	PRESIDENT & CSO	— mixed-class rows	773,821 mixed-class rows	$666,412	—	19 Feb 2025	3/4/5
NORTHERN TRUST CORP	13F	Company	0.26%	343,066	$572,921	—	31 Dec 2024	13F
LOS ANGELES CAPITAL MANAGEMENT LLC	13F	Company	0.23%	301,419	$503,370	—	31 Dec 2024	13F
Deutsche Girozentrale DekaBank	13F	Individual	0.03%	41,000	$443,000	—	31 Dec 2024	13F
XTX Topco Ltd	13F	Company	0.2%	263,856	$440,640	—	31 Dec 2024	13F
D. E. Shaw & Co., Inc.	13F	Company	0.19%	255,878	$427,316	—	31 Dec 2024	13F
JPMORGAN CHASE & CO	13F	Company	0.18%	236,046	$394,197	—	31 Dec 2024	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.16%	216,707	$361,901	—	31 Dec 2024	13F
DIADEMA PARTNERS LP	13F	Company	0.15%	197,680	$330,126	—	31 Dec 2024	13F
Peter S. Garcia	3/4/5	CHIEF FINANCIAL OFFICER	— mixed-class rows	201,516 mixed-class rows	$313,511	—	14 Aug 2024	3/4/5
Nuveen Asset Management, LLC	13F	Company	0.12%	164,790	$275,199	—	31 Dec 2024	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.11%	151,620	$253,205	—	31 Dec 2024	13F
Qube Research & Technologies Ltd	13F	Company	0.1%	138,470	$231,245	—	31 Dec 2024	13F
BANK OF NOVA SCOTIA	13F	Company	0.08%	105,306	$175,861	—	31 Dec 2024	13F
DEUTSCHE BANK AG\	13F	Company	0.08%	101,113	$168,859	—	31 Dec 2024	13F
Bank of New York Mellon Corp	13F	Company	0.07%	90,003	$150,305	—	31 Dec 2024	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.06%	75,000	$125,250	—	31 Dec 2024	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.05%	71,730	$119,789	—	31 Dec 2024	13F
Aberdeen Group plc	13F	Company	0.05%	66,211	$110,572	—	31 Dec 2024	13F
BARCLAYS PLC	13F	Company	0.05%	65,122	$108,754	—	31 Dec 2024	13F
SEI INVESTMENTS CO	13F	Company	0.05%	60,795	$101,528	—	31 Dec 2024	13F
Vanguard Personalized Indexing Management, LLC	13F	Company	0.03%	43,056	$71,904	—	31 Dec 2024	13F
RHUMBLINE ADVISERS	13F	Company	0.03%	42,516	$70,996	—	31 Dec 2024	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.03%	41,985	$70,114	—	31 Dec 2024	13F
Nan Fung Group Holdings Ltd	13F	Company	0.03%	41,950	$70,057	—	31 Dec 2024	13F
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC	13F	Company	0.03%	39,131	$65,349	—	31 Dec 2024	13F

Institutional Holders of ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) as of Q1 2025

As of 31 Mar 2025, ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) was held by 83 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 34,764,459 shares. The largest 10 holders included venBio Partners LLC, Redmile Group, LLC, TANG CAPITAL MANAGEMENT LLC, BlackRock, Inc., VANGUARD GROUP INC, BANK OF AMERICA CORP /DE/, Almitas Capital LLC, ACADIAN ASSET MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 83 institutional shareholders reporting positions in this security for the Q1 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 holders

Q1 2025 holders

Holder diff

-2

Investor	Q4 2024 Shares	Q1 2025 Shares	Share Diff	Share Chg %	Q4 2024 Value $	Q1 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.